Judge Won't Compel Boston Scientific Privileged Docs
Plaintiffs in the ongoing consolidated securities fraud action against Boston Scientific Corp. have lost a bid to compel evidence related to the company's internal investigation of a 2004 Taxus stent recall...To view the full article, register now.
Already a subscriber? Click here to view full article